Cytovale, a medical diagnostics company, announced that its IntelliSep® test received FDA clearance, aiding clinicians in early detection of the No. 1 cause of death in hospitals: sepsis.
Much of the research and clinical studies for this new technology took place right here in Baton Rouge, at Our Lady of the Lake Regional Medical Center and its Emergency Department. Since 2015, Our Lady of the Lake has partnered with Cytovale on more than half a dozen studies that led to this groundbreaking tool.